Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are used to reduce high blood glucose levels in patients with diabetes. They function by inhibiting the SGLT2 proteins in the kidney, which reabsorb glucose back into the bloodstream. Commonly prescribed sodium-glucose co-transporter 2 (SGLT2) inhibitors include Invokana (canaglifozin), Farxiga (dapagliflozin) and Jardiance (empaglifozin).
Drugs classified as Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors are frequently used to treat the following conditions:
Click on a drug below in order to find information and discounted prices at pharmacies near you.
Farxiga
Invokana
Jardiance